Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of centrally acting drugs. Its stereochemistry enables selective interaction with biological targets, making it valuable in the production of active pharmaceutical ingredients (APIs) for neurological and psychiatric disorders. Commonly employed in the preparation of serotonin and dopamine modulators due to its structural compatibility with neurotransmitter receptors. The tert-butyloxycarbonyl (Boc) protecting group allows for controlled deprotection during multi-step syntheses, ensuring high yield and purity in final drug compounds.